Page 301 - Tata_Chemicals_yearly-reports-2019-20
P. 301

Integrated report             Statutory reportS          Financial StatementS
                                                                                   Consolidated


                                                                                                        ` in crore
                                                                      TCL                     RALLIS
             Provident Fund                                        As at        As at        As at        As at
                                                           March 31, 2020 March 31, 2019 March 31, 2020 March 31, 2019
             plan assets at the end of the year                  326.37        329.40       91.99         81.43
             present value of funded obligation                  340.08        336.71       89.26         77.72
             Amount recognised in the Consolidated Balance Sheet  (13.71)      (7.31)           -            -


            assumptions used in determining present value of obligation of interest rate guarantee under a deterministic approach:
                                                                                             As at        As at
                                                                                     March 31, 2020 March 31, 2019
             guaranteed rate of return                                                      8.50%        8.65%
             discount rate for remaining term to maturity of investments               6.35% - 6.83%  7.75% - 7.78%
             discount rate                                                                  6.05%        7.70%
             expected rate of return on investments                                    7.69% - 7.86%  7.99% - 8.13%

            41.  Segment information
            41.1 Continuing operations

                (a)  Information about operating segments
                Reportable Segments approved by Board of Directors are as under:
                -   Basic chemistry products : soda ash, salt and other bulk chemicals
                -   Specialty products : nutrition solutions, agri solutions and advance materials
                  the corresponding information for the previous periods presented in Consolidated Financial Statements has been restated (note 36).
                                                                                                        ` in crore
                                                                                        Year ended   Year ended
                                                                                     March 31, 2020 March 31, 2019
                 1.   Segment revenue (Revenue from operations)
                     (i)   Basic chemistry products                                        8,013.74     8,309.05
                     (ii)   Speciality products                                            2,328.85     2,026.29
                                                                                         10,342.59     10,335.34
                     Inter segment revenue                                                  (10.06)      (15.75)
                                                                                         10,332.53    10,319.59
                     unallocated                                                             24.22        17.13
                                                                                         10,356.75    10,336.72
                 2.   Segment result (Reconciliation with profit from continuing operations)
                     (i)   Basic chemistry products                                        1,355.51     1,303.61
                     (ii)   Speciality products                                             166.90       172.13
                 Total segment results                                                    1,522.41     1,475.74
                 net unallocated income/(expenditure)                                        71.41       216.01
                 Finance costs                                                             (341.91)     (353.70)
                 Profit before share of profit/loss from investment in joint ventures and tax     1,251.91    1,338.05
                 Share of (loss)\profit of joint ventures (net of tax)                       (3.85)       99.21
                 tax expense                                                               (219.65)     (274.44)
                 Profit for the year from continuing operations                           1,028.41     1,162.82






                                                                                                           299
   296   297   298   299   300   301   302   303   304   305   306